MeiraGTx Holdings plc
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.
MeiraGTx Holdings plc
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.
meiragtx.com
430 East 29th Street, New York, 10016, US
Details
Year founded
2015
Revenue
10M-25M
Employees
201-500
Number of locations
3
NAICS
325413
SIC
2836
Products & Services
Outlines the company's specialized services and operational strengths.
- Gene therapy treatments
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- Cell expansion suites
- Bulk production virus suites
- Downstream purification suites
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
TRUE
Our production algorithm is showing that meiragtx holdings plc is ramping up production.
Target industries
Employees working in MeiraGTx Holdings plc
News
MeiraGTx Holdings plc (NASDAQ:MGTX): Is Breakeven Near?
MeiraGTx Holdings plc (NASDAQ:MGTX): Is Breakeven Near?
MeiraGTx Holdings is bordering on breakeven, according to the 3 American Biotechs analysts. They anticipate the company to incur a final loss in 2024, before...
Locations (3)
MeiraGTx Holdings plc
430 East 29th Street, New York, 10016, US
Meiragtx
britannia walk, london n1 7ng
MeiraGTx Netherlands b.v.
Paalbergweg 2, 1105 AG Amsterdam, Netherlands
Frequently Asked Questions
What services & capabilities does MeiraGTx Holdings plc offer?
MeiraGTx Holdings plc offers a range of services and capabilities, including Gene therapy treatments.
What kind of equipment does MeiraGTx Holdings plc use?
MeiraGTx Holdings plc uses a variety of equipment, including Cell expansion suites.
What are the target industries of MeiraGTx Holdings plc?
MeiraGTx Holdings plc serves several industries, including the medical industry.
How many locations does MeiraGTx Holdings plc operate?
MeiraGTx Holdings plc operates from 3 locations.
What is the annual revenue of MeiraGTx Holdings plc?
MeiraGTx Holdings plc's revenue is $15.92M.
Where are the headquarters of MeiraGTx Holdings plc?
The headquarters of MeiraGTx Holdings plc are located in 430 east 29th street, new york, new york 10016, united states.
What is the NAICS code for MeiraGTx Holdings plc?
The NAICS code for MeiraGTx Holdings plc is 325413.
How many employees does MeiraGTx Holdings plc have?
MeiraGTx Holdings plc has 358 employees.
What is the official website of MeiraGTx Holdings plc?
The official website of MeiraGTx Holdings plc is https://www.meiragtx.com.
When was MeiraGTx Holdings plc founded?
MeiraGTx Holdings plc was founded in 2015.